.

New Deal

New Deal

Announced

26 Mar 2016

Completed

26 Mar 2016

BRIDGEBIO PHARMA LLC / PERCEPTIVE LIFE SCIENCES / KKR & CO / Acquisition / Private / £5m

Financials

Edit Data

Transaction Value-

Consideration Type-

Capital Owned-

Capital Bid For-

EV/Sales-

EV/EBITDA-

Share Price Premium-

One Off Charge-

target

Bridgebio Pharma

bidder

Kkr & Co

bidder

Perceptive Life Sciences

Sources

Edit

Tags

Edit

pharmaceuticals

Pharmaceuticals

Acquisition

Private

Completed

Friendly

United States

Private Equity

Synopsis

Edit

Equity investment by KKR and Perceptive Advisors in BridgeBio, a developer of precision medicinal therapies for the treatment of genetic pediatric diseases.

Service Providers (1)

Dealmakers

legal advisors

Latham & Watkins

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US